{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:21:33Z","timestamp":1740122493082,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-022-02722-5","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T21:20:20Z","timestamp":1668028820000},"page":"175-180","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Use of SAMe-TT2R2 in a racially diverse anticoagulation clinic: prediction of optimal anticoagulation"],"prefix":"10.1007","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5916-0311","authenticated-orcid":false,"given":"Kunkun","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengistu A","family":"Simegn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoran","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard W","family":"Asinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,9]]},"reference":[{"issue":"2 Suppl","key":"2722_CR1","doi-asserted-by":"publisher","first-page":"e44S","DOI":"10.1378\/chest.11-2292","volume":"141","author":"W Ageno","year":"2012","unstructured":"Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G (2012) Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of chest physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e44S-e88S. https:\/\/doi.org\/10.1378\/chest.11-2292","journal-title":"Chest"},{"issue":"1","key":"2722_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ahj.2015.03.017","volume":"170","author":"SD Pokorney","year":"2015","unstructured":"Pokorney SD, Simon DN, Thomas L et al (2015) Patients\u2019 time in therapeutic range on warfarin among US patients with atrial fibrillation: results from ORBIT-AF registry. Am Heart J 170(1):141-148e1. https:\/\/doi.org\/10.1016\/j.ahj.2015.03.017","journal-title":"Am Heart J"},{"issue":"2 Suppl","key":"2722_CR3","doi-asserted-by":"publisher","first-page":"e152S","DOI":"10.1378\/chest.11-2295","volume":"141","author":"A Holbrook","year":"2012","unstructured":"Holbrook A, Schulman S, Witt DM et al (2012) Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of chest physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e152S-e184S. https:\/\/doi.org\/10.1378\/chest.11-2295","journal-title":"Chest"},{"issue":"7","key":"2722_CR4","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1111\/bcp.13234","volume":"83","author":"L Monaco","year":"2017","unstructured":"Monaco L, Biagi C, Conti V et al (2017) Safety profile of the direct oral anticoagulants: an analysis of the WHO database of adverse drug reactions. Br J Clin Pharmacol 83(7):1532\u20131543. https:\/\/doi.org\/10.1111\/bcp.13234","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"2722_CR5","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jacc.2020.08.037","volume":"77","author":"PA Heidenreich","year":"2010","unstructured":"Heidenreich PA, Estes NAM 3rd, Fonarow GC et al (2010) 2020 update to the 2016 ACC\/AHA clinical performance and quality measures for adults with atrial fibrillation or atrial flutter: a report of the American College of Cardiology\/American Heart Association task force on performance measures. J Am Coll Cardiol 77(3):326\u2013341. https:\/\/doi.org\/10.1016\/j.jacc.2020.08.037","journal-title":"J Am Coll Cardiol"},{"key":"2722_CR6","doi-asserted-by":"publisher","unstructured":"AFFIRM Investigators (2002)\u00a0Atrial fibrillation follow-up investigation of rhythm management. Baseline characteristics of patients with atrial fibrillation: the AFFIRM Study. \u00a0Am Heart J 143(6):991\u20131001. https:\/\/doi.org\/10.1067\/mhj.2002.122875","DOI":"10.1067\/mhj.2002.122875"},{"issue":"5","key":"2722_CR7","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1378\/chest.13-0054","volume":"144","author":"S Apostolakis","year":"2013","unstructured":"Apostolakis S, Sullivan RM, Olshansky B, Lip GYH (2013) Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT2R2 score. Chest 144(5):1555\u20131563. doi:https:\/\/doi.org\/10.1378\/chest.13-0054","journal-title":"Chest"},{"key":"2722_CR8","unstructured":"National Institute for Health and Care Excellence (NICE) Implementation Collaborate Consensus (2014).\u00a0http:\/\/www.europeaf.org\/app\/webroot\/files\/file\/NIC%20NOAC%20Consensus_Updated_06-03-2014.pdf. Accessed 9 Feb\u00a02022"},{"issue":"5","key":"2722_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N et al (2021) 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 42(5):373\u2013498. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612","journal-title":"Eur Heart J"},{"issue":"5","key":"2722_CR10","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/europace\/euu353","volume":"17","author":"RR Abumuaileq","year":"2015","unstructured":"Abumuaileq RR, Abu-Assi E, Raposeiras-Roubin S et al (2015) Evaluation of SAMe-TT2R2 risk score for predicting the quality of anticoagulation control in a real-world cohort of patients with non-valvular atrial fibrillation on vitamin-K antagonists. Europace 17(5):711\u2013717. doi:https:\/\/doi.org\/10.1093\/europace\/euu353","journal-title":"Europace"},{"issue":"4","key":"2722_CR11","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1160\/TH15-02-0169","volume":"114","author":"M Ruiz-Ortiz","year":"2015","unstructured":"Ruiz-Ortiz M, Bertomeu V, Cequier \u00c1, Mar\u00edn F, Anguita M (2015) Validation of the SAMe-TT2R2 score in a nationwide population of nonvalvular atrial fibrillation patients on vitamin K antagonists. Thromb Haemost 114(4):695\u2013701. doi:https:\/\/doi.org\/10.1160\/TH15-02-0169","journal-title":"Thromb Haemost"},{"issue":"11","key":"2722_CR12","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.amjmed.2015.05.036","volume":"128","author":"V Rold\u00e1n","year":"2015","unstructured":"Rold\u00e1n V, Cancio S, G\u00e1lvez J et al (2015) The SAMe-TT2R2  score predicts poor anticoagulation control in AF patients: a prospective \u2018real-world\u2019 inception cohort study. Am J Med 128(11):1237\u20131243. https:\/\/doi.org\/10.1016\/j.amjmed.2015.05.036","journal-title":"Am J Med"},{"issue":"11","key":"2722_CR13","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.amjmed.2014.05.023","volume":"127","author":"P Gallego","year":"2014","unstructured":"Gallego P, Rold\u00e1n V, Marin F et al (2014) SAMe-TT2R2  score, time in therapeutic range, and outcomes in anticoagulated patients with atrial fibrillation. Am J Med 127(11):1083\u20131088. doi:https:\/\/doi.org\/10.1016\/j.amjmed.2014.05.023","journal-title":"Am J Med"},{"key":"2722_CR14","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ijcard.2016.04.131","volume":"216","author":"M Proietti","year":"2016","unstructured":"Proietti M, Lane DA, Lip GY (2016) Relation of the SAMe-TT2R2 score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: Observations from the SPORTIF trials. Int J Cardiol 216:168\u2013172. doi:https:\/\/doi.org\/10.1016\/j.ijcard.2016.04.131","journal-title":"Int J Cardiol"},{"issue":"3","key":"2722_CR15","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1378\/chest.13-2976","volume":"146","author":"GYH Lip","year":"2014","unstructured":"Lip GYH, Haguenoer K, Saint-Etienne C, Fauchier L (2014) Relationship of the SAMe-TT2R2  score to poor-quality anticoagulation, stroke, clinically relevant bleeding, and mortality in patients with atrial fibrillation. Chest 146(3):719\u2013726. doi:https:\/\/doi.org\/10.1378\/chest.13-2976","journal-title":"Chest"},{"issue":"3","key":"2722_CR16","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1055\/s-0038-1651587","volume":"69","author":"FR Rosendaal","year":"1993","unstructured":"Rosendaal FR, Cannegieter SC, van der Meer FJ, Bri\u00ebt E (1993) A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 69(3):236\u2013239","journal-title":"Thromb Haemost"},{"issue":"1","key":"2722_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1353\/hpu.2008.0002","volume":"19","author":"VK Bhandari","year":"2018","unstructured":"Bhandari VK, Wang F, Bindman AB, Schillinger D (2018) Quality of anticoagulation control: do race and language matter? J Health Care Poor Underserv 19(1):41\u201355. https:\/\/doi.org\/10.1353\/hpu.2008.0002","journal-title":"J Health Care Poor Underserv"},{"issue":"10","key":"2722_CR18","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/STROKEAHA.107.508580","volume":"39","author":"AY Shen","year":"2008","unstructured":"Shen AY, Yao JF, Brar SS, Jorgensen MB, Wang X, Chen W (2008) Racial\/Ethnic differences in ischemic stroke rates and the efficacy of warfarin among patients with atrial fibrillation. Stroke 39(10):2736\u20132743. doi:https:\/\/doi.org\/10.1161\/STROKEAHA.107.508580","journal-title":"Stroke"},{"issue":"3","key":"2722_CR19","doi-asserted-by":"publisher","first-page":"e0150674","DOI":"10.1371\/journal.pone.0150674","volume":"11","author":"PH Chan","year":"2016","unstructured":"Chan PH, Hai JJ, Chan EW et al (2016) Use of the SAMe-TT2R2 score to predict good anticoagulation control with warfarin in Chinese patients with atrial fibrillation: relationship to ischemic stroke incidence. PLoS ONE 11(3):e0150674. https:\/\/doi.org\/10.1371\/journal.pone.0150674","journal-title":"PLoS ONE"},{"issue":"12","key":"2722_CR20","doi-asserted-by":"publisher","first-page":"641","DOI":"10.11622\/smedj.2019143","volume":"61","author":"R Krittayaphong","year":"2020","unstructured":"Krittayaphong R, Winijkul A, Pirapatdit A et al (2020) SAMe-TT2R2 score for prediction of suboptimal time in therapeutic range in a Thai population with atrial fibrillation. Singap Med J 61(12):641\u2013646. doi:https:\/\/doi.org\/10.11622\/smedj.2019143","journal-title":"Singap Med J"},{"issue":"1","key":"2722_CR21","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.08.030","volume":"26","author":"N Bernaitis","year":"2017","unstructured":"Bernaitis N, Ching CK, Chen L et al (2017) The sex, age, medical history, treatment, tobacco use, race risk (SAMe-TT2R2) Score predicts warfarin control in a Singaporean population. J Stroke Cerebrovasc Dis 26(1):64\u201369. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2016.08.030","journal-title":"J Stroke Cerebrovasc Dis"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-022-02722-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-022-02722-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-022-02722-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T08:27:12Z","timestamp":1676363232000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-022-02722-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,9]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["2722"],"URL":"https:\/\/doi.org\/10.1007\/s11239-022-02722-5","relation":{},"ISSN":["1573-742X"],"issn-type":[{"type":"electronic","value":"1573-742X"}],"subject":[],"published":{"date-parts":[[2022,11,9]]},"assertion":[{"value":"17 October 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interests, no financial disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}